Free Trial

MaxCyte (MXCT) Competitors

GBX 298.95
-5.05 (-1.66%)
(As of 09/6/2024 12:05 PM ET)

MXCT vs. HRI, RSG, OCN, LOOK, PAY, CSN, TRMR, HUR, ACRL, and TUNG

Should you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include Herald (HRI), Resolute Mining (RSG), Ocean Wilsons (OCN), Lookers (LOOK), PayPoint (PAY), Chesnara (CSN), Tremor International (TRMR), Hurricane Energy (HUR), Accrol Group (ACRL), and Tungsten (TUNG). These companies are all part of the "business services" industry.

MaxCyte vs.

Herald (LON:HRI) and MaxCyte (LON:MXCT) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

MaxCyte received 50 more outperform votes than Herald when rated by MarketBeat users. Likewise, 68.92% of users gave MaxCyte an outperform vote while only 67.76% of users gave Herald an outperform vote.

CompanyUnderperformOutperform
HeraldOutperform Votes
103
67.76%
Underperform Votes
49
32.24%
MaxCyteOutperform Votes
153
68.92%
Underperform Votes
69
31.08%

In the previous week, MaxCyte had 2 more articles in the media than Herald. MarketBeat recorded 2 mentions for MaxCyte and 0 mentions for Herald. MaxCyte's average media sentiment score of 0.30 beat Herald's score of -0.18 indicating that MaxCyte is being referred to more favorably in the news media.

Company Overall Sentiment
Herald Neutral
MaxCyte Neutral

Herald has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Herald, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Herald£63.34M17.64£48.12M£0.812,506.17
MaxCyte£45.44M6.91-£35.43M-£0.26-1,149.81

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Herald
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
MaxCyte
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Herald has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500.

Herald has a net margin of 75.97% compared to MaxCyte's net margin of -77.97%. Herald's return on equity of 3.77% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
Herald75.97% 3.77% 2.45%
MaxCyte -77.97%-15.33%-11.07%

48.1% of Herald shares are owned by institutional investors. Comparatively, 75.5% of MaxCyte shares are owned by institutional investors. 5.3% of Herald shares are owned by company insiders. Comparatively, 1.5% of MaxCyte shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Herald beats MaxCyte on 9 of the 15 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MXCT vs. The Competition

MetricMaxCyteMedical Devices IndustryMedical SectorLON Exchange
Market Cap£314.17M£2.07B£5.68B£1.59B
Dividend YieldN/A2.49%2.73%10.87%
P/E Ratio-1,149.81236.57112.811,864.45
Price / Sales6.91283.251,778.72385,791.44
Price / Cash1.9715.8138.8934.41
Price / Book1.422.804.982.58
Net Income-£35.43M£68.71M£114.80M£158.17M
7 Day Performance-8.02%-1.83%-1.52%-1.56%
1 Month Performance-12.07%-1.38%8.47%0.27%
1 Year Performance-0.35%14.38%12.48%19.33%

MaxCyte Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HRI
Herald
0 of 5 stars
0.00 / 5 stars
GBX 2,160
flat
N/A+14.3%£1.19B£63.34M2,666.676,600
RSG
Resolute Mining
0.4551 of 5 stars
0.46 / 5 stars
GBX 34
+1.5%
GBX 37
+8.8%
+86.1%£724.20M£631.07M1,700.0040,000Gap Up
OCN
Ocean Wilsons
0 of 5 stars
0.00 / 5 stars
GBX 1,445
flat
N/A+38.6%£510.95M£519.35M1,070.3774,200Gap Down
LOOK
Lookers
0 of 5 stars
0.00 / 5 stars
GBX 129.80
flat
N/AN/A£503.22M£4.48B811.2538
PAY
PayPoint
0.3971 of 5 stars
0.40 / 5 stars
GBX 687
+1.3%
GBX 675
-1.7%
+21.4%£497.46M£297.90M1,402.041,260Dividend Increase
CSN
Chesnara
0 of 5 stars
0.00 / 5 stars
GBX 262.50
+0.6%
N/A-5.0%£396.24M£369.50M2,187.505,700News Coverage
TRMR
Tremor International
0 of 5 stars
0.00 / 5 stars
GBX 201.20
+1.8%
N/A+29.6%£293.13M£343.77M-1,829.09167
HUR
Hurricane Energy
0 of 5 stars
0.00 / 5 stars
N/AN/A+0.0%£155.02M£275.50M194.755,660High Trading Volume
ACRL
Accrol Group
0 of 5 stars
0.00 / 5 stars
GBX 39
+0.5%
N/A+25.8%£124.36M£221.16M-3,900.00456
TUNG
Tungsten
0 of 5 stars
0.00 / 5 stars
N/AN/A+0.0%£69.09M£36.39M-19.50200News Coverage

Related Companies and Tools

This page (LON:MXCT) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners